Published in Lancet on November 29, 2014
Changes in health in England, with analysis by English regions and areas of deprivation, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 2.15
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis. Am J Gastroenterol (2016) 1.76
Volatile Biomarkers in Breath Associated With Liver Cirrhosis - Comparisons of Pre- and Post-liver Transplant Breath Samples. EBioMedicine (2015) 0.91
Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol (2015) 0.85
Liver disease in the UK. Lancet (2015) 0.82
Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies. J Clin Endocrinol Metab (2015) 0.81
New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England. J Viral Hepat (2016) 0.81
Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study. BMJ Open (2015) 0.79
UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care. Gut (2017) 0.79
Immune dysfunction in acute alcoholic hepatitis. World J Gastroenterol (2015) 0.78
Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt? Am J Physiol Gastrointest Liver Physiol (2015) 0.77
Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence. Curr Opin Infect Dis (2015) 0.77
The effect of glass shape on alcohol consumption in a naturalistic setting: a feasibility study. Pilot Feasibility Stud (2015) 0.77
General and Abdominal Adiposity and Risk of Death in HBV Versus Non-HBV Carriers: A 10-Year Population-based Cohort Study. Medicine (Baltimore) (2016) 0.77
Hepatitis C - Assessment to Treatment Trial (HepCATT) in primary care: study protocol for a cluster randomised controlled trial. Trials (2016) 0.76
Alcohol: taking a population perspective. Nat Rev Gastroenterol Hepatol (2016) 0.76
A synthetic biology-based device prevents liver injury in mice. J Hepatol (2016) 0.76
Does Industry-Driven Alcohol Marketing Influence Adolescent Drinking Behaviour? A Systematic Review. Alcohol Alcohol (2016) 0.75
Liver disease in the UK. Lancet (2015) 0.75
ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial. BMJ Open (2016) 0.75
Long-term outcome of patients with liver cirrhosis admitted to a general intensive care unit. Ann Intensive Care (2017) 0.75
The impact of alcohol care teams on emergency secondary care use following a diagnosis of alcoholic liver disease - a national cohort study. BMC Public Health (2016) 0.75
Alcoholic Liver Disease in Asia, Europe, and North America. Gastroenterology (2016) 0.75
Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study. QJM (2015) 0.75
The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011. PLoS One (2016) 0.75
Hepatology training in the UK. Lancet (2016) 0.75
THE USE OF AN ACELLULAR OXYGEN CARRIER IN A HUMAN LIVER MODEL OF NORMOTHERMIC MACHINE PERFUSION. Transplantation (2017) 0.75
Trends in alcohol-related admissions to hospital by age, sex and socioeconomic deprivation in England, 2002/03 to 2013/14. BMC Public Health (2017) 0.75
Patient understanding of liver cirrhosis and improvement using multimedia education. Frontline Gastroenterol (2017) 0.75
Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there? J Int AIDS Soc (2017) 0.75
Direct-acting antiviral agents for HCV infection affecting people who inject drugs. Nat Rev Gastroenterol Hepatol (2017) 0.75
Advanced chronic liver disease in the last year of life: a mixed methods study to understand how care in a specialist liver unit could be improved. BMJ Open (2017) 0.75
Modeling Combination HCV Prevention among HIV-infected Men Who Have Sex With Men and People Who Inject Drugs. AIDS Rev (2017) 0.75
Liver cirrhosis in England-an observational study: are we measuring its burden occurrence correctly? BMJ Open (2017) 0.75
Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet (2008) 11.44
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet (2010) 8.02
Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet (2013) 6.19
Global overview of injecting drug use and HIV infection among injecting drug users. AIDS (2004) 5.45
How ideology shapes the evidence and the policy: what do we know about cannabis use and what should we do? Addiction (2010) 5.08
Cause-specific mortality rates in sub-Saharan Africa and Bangladesh. Bull World Health Organ (2006) 4.12
Child survival gains in Tanzania: analysis of data from demographic and health surveys. Lancet (2008) 4.03
Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. BMJ (2010) 3.59
Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med (2015) 3.47
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ (2012) 3.46
Acute liver failure. Lancet (2010) 3.39
An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis (2005) 3.25
Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr (2006) 3.03
Mapping malaria transmission in West and Central Africa. Trop Med Int Health (2006) 3.02
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction (2011) 2.95
Distinct molecular phenotypes in bovine prion diseases. EMBO Rep (2004) 2.90
Providing treatment to prisoners with mental disorders: development of a policy. Selective literature review and expert consultation exercise. Br J Psychiatry (2003) 2.79
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology (2013) 2.76
Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut (2010) 2.66
Could targeted food taxes improve health? J Epidemiol Community Health (2007) 2.66
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood (2007) 2.61
Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction (2010) 2.59
Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis (2010) 2.56
Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia. J Urban Health (2006) 2.52
B-cell responses to vaccination at the extremes of age. Nat Rev Immunol (2009) 2.50
Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol (2004) 2.48
Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction (2006) 2.46
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings. Addiction (2012) 2.45
Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS (2002) 2.40
Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30
Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol (2004) 2.28
Stressful incidents, stress and coping strategies in the pre-registration house officer year. Med Educ (2002) 2.26
The Academy of Medical Royal Colleges' statement on clinical research in the UK. Lancet (2009) 2.23
An applied ecological framework for evaluating infrastructure to promote walking and cycling: the iConnect study. Am J Public Health (2011) 2.19
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15
Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol (2003) 2.11
UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ (2004) 2.11
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology (2013) 2.08
Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis. Int J Epidemiol (2013) 2.08
Paracetamol: are therapeutic doses entirely safe? Lancet (2006) 2.07
Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. Addiction (2006) 2.06
The epidemiology of malaria in Papua New Guinea. Trends Parasitol (2003) 2.03
Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ (2004) 2.03
Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health (2005) 2.01
Could campaigns like Dry January do more harm than good? BMJ (2016) 2.01
Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00
Increasing burden of liver disease in patients with HIV infection. Lancet (2011) 1.98
Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure. Liver Transpl (2008) 1.97
Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia. Addiction (2007) 1.95
Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact. Vaccine (2013) 1.94
Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology (2009) 1.94
Expanding the idea of one health. J Am Vet Med Assoc (2015) 1.93
Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros (2011) 1.93
Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr (2012) 1.91
Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5"). Addiction (2006) 1.87
Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of Plasmodium falciparum. Am J Trop Med Hyg (2006) 1.86
Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol (2003) 1.84
Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol (2013) 1.83
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut (2010) 1.83
A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J Hepatol (2007) 1.82
Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction (2007) 1.81
Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. J Hepatol (2005) 1.79
Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology (2013) 1.78
Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004. Int J Epidemiol (2006) 1.78
A critical review of the health-related quality of life of children and adolescents after liver transplantation. Liver Transpl (2005) 1.75
Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol (2003) 1.73
Modernising Medical Careers: a response from two Presidents of The Royal Colleges. Lancet (2007) 1.72
Estimating the duration of Plasmodium falciparum infection from trials of indoor residual spraying. Am J Trop Med Hyg (2004) 1.71
Tackling malaria today. BMJ (2008) 1.70
Projections of alcohol deaths--a wake-up call. Lancet (2011) 1.68
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations. Hepatology (2011) 1.67
Binge drinking, sexual behaviour and sexually transmitted infection in the UK. Int J STD AIDS (2007) 1.67
Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med (2002) 1.66
'Nipped in the Budd': hepatic venous outflow obstruction in evolution. Eur J Gastroenterol Hepatol (2005) 1.66
Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol (2012) 1.66
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation (2003) 1.63
Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT. Am J Gastroenterol (2003) 1.63
Alcohol imagery and branding, and age classification of films popular in the UK. Int J Epidemiol (2011) 1.62
One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation (2004) 1.62
Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators. J Epidemiol Community Health (2004) 1.62
Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up. J Hepatol (2009) 1.61
Adolescent alcohol and tobacco use and early socioeconomic position: the ALSPAC birth cohort. Pediatrics (2011) 1.60
Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol (2005) 1.60
Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology (2003) 1.59
Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology (2003) 1.59
Host population persistence in the face of introduced vector-borne diseases: Hawaii amakihi and avian malaria. Proc Natl Acad Sci U S A (2005) 1.59
Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl (2004) 1.58
Child deaths: confidential enquiry into the role and quality of UK primary care. Br J Gen Pract (2009) 1.58
Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability. J Neurosci (2003) 1.58
Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis. J Hepatol (2002) 1.57
Estimating long-term trends in the incidence and prevalence of opiate use/injecting drug use and the number of former users: back-calculation methods and opiate overdose deaths. Am J Epidemiol (2004) 1.57